AC-052-321
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AC-052-321, covering 2012-08-03 to 2012-08-03. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443 [Phase 3]